இம்ய்யுநஸேயீ ஆய்வகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இம்ய்யுநஸேயீ ஆய்வகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இம்ய்யுநஸேயீ ஆய்வகம் Today - Breaking & Trending Today

Lessons from India's jab rollout


Lessons from India s jab rollout
17
published :
29 Jan 2021 at 04:00
17
In just 12 days after India launched its Covid-19 vaccination programme on Jan 16 touted as the world s largest coronavirus jab rollout more than 2.3 million healthcare workers have been inoculated against the virus. In Phase I of the drive, India plans to vaccinate some 30 million healthcare and frontline workers.
For India, such large-scale vaccinations are not new. Every year, 27 million infants are immunised against 12 diseases. The government s polio immunisation drive, which successfully eradicated the disease from India, has even set the global standard for such programmes.
Worth noting is the fact that the two Covid-19 vaccines authorised for emergency use in the country are domestically manufactured the AstraZeneca/Oxford-developed Covishield, which is produced by the Serum Institute of India; and Covaxin, developed indigenously by Bharat ....

United States , Sri Lanka , Zydus Cadila , Vasudhaiva Kutumbakam , Narendra Modi , Asean Covid , Indian Department Of Biotechnology , National Biopharma Mission , National Immunogenicity Biologics Evaluation Centre , Indian Council For Medical Research , World Health Organization , Melinda Gates Foundation , World Bank , Mission Covid Suraksha , Immunoassay Laboratory Of The Translational Health Science , Technology Institute , Serum Institute Of India , Electronic Vaccine Intelligence Network , Response Fund , Oxford Developed Covishield , Serum Institute , Bharat Biotech , Indian Council , Immunoassay Laboratory , Translational Health Science , Indian Department ,